GO:0060003 copper ion export: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060003 copper ion export is the directed movement of copper ions out of a cell or organelle, a process essential for preventing copper toxicity and maintaining metal homeostasis.
• Copper export is mediated by P1B-type ATPases such as ATP7A and ATP7B in humans, and CopA/CopB in bacteria, which use ATP hydrolysis to pump copper across membranes.
• Defects in copper export cause Menkes disease (ATP7A) and Wilson disease (ATP7B), highlighting its clinical importance.
• Copper export also influences cancer biology, as cuproptosis induction by compounds like triptolide relies on copper homeostasis.
• In pathogenic bacteria, copper export systems like CopA are critical for virulence and survival within hosts.
• Research on copper ion export uses CRISPR knockout, point mutations, knock-in reporters, and overexpression models to dissect gene function and transport mechanisms.
Description
Copper is an essential trace element that serves as a cofactor for enzymes involved in respiration, antioxidant defense, and neurotransmitter synthesis, but free copper is highly toxic because it catalyzes reactive oxygen species formation. To maintain safe intracellular levels, cells have evolved dedicated export systems that actively pump copper ions out of the cytoplasm or organelles. The Gene Ontology term GO:0060003 copper ion export describes this directed movement of copper ions out of a cell or organelle. This process is conserved from bacteria to humans and is fundamental to copper homeostasis. In humans, copper export is primarily carried out by two P1B-type ATPases, ATP7A and ATP7B, which transport copper across the plasma membrane or into the trans-Golgi network for incorporation into cuproenzymes. In bacteria, copper export systems such as CopA and CopB are critical for resistance to copper stress and for virulence. Understanding copper ion export is therefore important for basic cell biology, infectious disease, and inherited disorders of copper metabolism. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0060003, covering its mechanism, key genes, disease links, and experimental approaches.
copper ion export At A Glance
| GO ID | GO:0060003 |
|---|---|
| GO term | copper ion export |
| Ontology | biological_process |
| Synonym | copper export |
| Major function | Directed movement of copper ions out of a cell or organelle |
| Cellular location | Plasma membrane, trans-Golgi network, and other organelle membranes |
| Key transporters | ATP7A, ATP7B (humans); CopA, CopB (bacteria) |
| Energy source | ATP hydrolysis by P1B-type ATPases |
| Associated diseases | Menkes disease, Wilson disease, copper-related toxicity |
What Is GO:0060003?
According to the Gene Ontology, GO:0060003 copper ion export is defined as the directed movement of copper ions out of a cell or organelle. This biological process encompasses the active transport of Cu+ or Cu2+ across lipid bilayers, typically mediated by dedicated membrane transporters that consume energy to move copper against its concentration gradient. The synonym copper export is also used. Copper ion export is distinct from copper ion import and intracellular copper ion transport, although it is functionally coupled to these processes to maintain overall copper homeostasis.
Why Is copper ion export Important in Cell Biology?
Copper ion export is essential for life because it prevents the accumulation of free copper, which can generate oxidative stress and damage proteins, lipids, and DNA. In humans, mutations in the copper-exporting ATPases ATP7A and ATP7B cause severe disorders: Menkes disease, characterized by copper deficiency in peripheral tissues due to defective export from enterocytes, and Wilson disease, characterized by copper overload in liver and brain due to impaired biliary excretion. In pathogenic bacteria, copper export systems are required for survival within host phagosomes and for full virulence. Moreover, copper export is emerging as a target in cancer therapy, as inducing cuproptosis through copper dysregulation can selectively kill cancer cells. Thus, understanding the molecular mechanisms of copper ion export has broad implications for genetics, infectious disease, and oncology.
• Prevents copper toxicity by removing excess copper from cells and organelles.
• Maintains copper homeostasis required for cuproenzyme biogenesis.
• Mutations in ATP7A cause Menkes disease, a fatal copper deficiency disorder.
• Mutations in ATP7B cause Wilson disease, a copper overload disorder.
• Bacterial copper export systems like CopA are essential for virulence.
• Copper export influences cancer cell survival and cuproptosis sensitivity.
• Astrocytes export copper to regulate brain copper levels.
• Glutaredoxin 1 modulates copper toxicity in intestinal inflammation.
• Copper export is a potential antimicrobial target in Streptococci.
• Studying copper export informs therapies for copper metabolism disorders.
What Happens During copper ion export?
Copper binding and delivery to the exporter
In simple terms: Copper ions are first picked up by chaperone proteins and handed over to the export pump.
In eukaryotic cells, copper is delivered to ATP7A and ATP7B by specific copper chaperones such as ATOX1, which transfers Cu+ to the cytosolic metal-binding domains of the ATPase. This delivery step ensures that copper is safely routed to the exporter and not released into the cytoplasm. In bacteria, copper may be delivered directly to CopA or via periplasmic chaperones. The binding of copper to the transporter triggers conformational changes that initiate the transport cycle.
ATP-driven conformational cycling
In simple terms: The pump uses energy from ATP to change shape and push copper across the membrane.
P1B-type ATPases like ATP7A, ATP7B, and CopA undergo a catalytic cycle involving phosphorylation of a conserved aspartate residue, which drives conformational transitions between E1 and E2 states. In the E1 state, the transporter has high affinity for copper and binds it from the cytosolic side. ATP binding and phosphorylation lead to the E2 state, which releases copper on the other side of the membrane. This cycle is powered by ATP hydrolysis and is essential for directed copper export.
Copper release on the extracytosolic side
In simple terms: Copper is released out of the cell or into an organelle lumen.
After the conformational change, copper is released into the extracellular space or into the lumen of organelles such as the trans-Golgi network. For ATP7A and ATP7B, this release can occur at the plasma membrane or into secretory vesicles, depending on cellular copper levels and tissue type. In bacteria, CopA pumps copper into the periplasm or out of the cell, while CopB may export copper from the cytoplasm. The released copper can then be bound by extracellular carriers or excreted.
Trafficking and regulation of exporters
In simple terms: The pumps move to different locations in the cell depending on how much copper is present.
Copper export activity is dynamically regulated by trafficking of the transporters. In high copper conditions, ATP7A and ATP7B relocalize from the trans-Golgi network to the plasma membrane or to vesicles to enhance copper efflux. This trafficking is mediated by signals in the transporter sequence and interacting proteins. In astrocytes, copper export is stimulated by elevated copper levels and involves ATP7A. Such regulation ensures that copper export matches cellular demand and prevents toxicity.
Key Genes Involved in GO:0060003 copper ion export
The following genes and proteins are central to copper ion export across species, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP7A | Copper-transporting ATPase; exports copper from cells, especially in intestine and brain | Mutations cause Menkes disease; studied for copper trafficking and neuronal copper homeostasis |
| ATP7B | Copper-transporting ATPase; exports copper into bile and participates in cuproenzyme loading | Mutations cause Wilson disease; target for liver copper metabolism research |
| ATOX1 | Copper chaperone that delivers copper to ATP7A/ATP7B | Essential for copper export; knockout leads to copper accumulation |
| CopA | Bacterial P1B-type ATPase that exports copper from cytoplasm | Virulence factor in Streptococcus pyogenes; model for bacterial copper homeostasis |
| CopB | Bacterial copper efflux ATPase | Studied in Enterococcus hirae for copper resistance |
| CTR1 | Copper importer (contrasts with export) | Provides context for copper homeostasis; not an exporter but relevant to balance |
| CCS | Copper chaperone for SOD1 | Indirectly affects copper distribution and export demand |
| MT1A | Metallothionein, binds copper | Modulates free copper available for export |
| SLC31A1 | Copper importer | Contributes to copper uptake, influencing export needs |
| GCLM | Glutamate-cysteine ligase modifier subunit | Affects redox balance and copper toxicity |
| GLRX1 | Glutaredoxin 1 | Promotes copper toxicity in intestinal epithelial cells; linked to export dysfunction |
| SOD1 | Cu/Zn superoxide dismutase | Requires copper; its maturation depends on copper availability |
| CP | Ceruloplasmin | Copper-containing ferroxidase; copper loading requires ATP7B |
| ALB | Albumin | Binds copper in plasma; affects copper distribution |
| COMMD1 | Copper metabolism protein | Regulates ATP7B stability and copper excretion |
| XIAP | Inhibitor of apoptosis | May influence copper-induced cell death pathways |
| FDX1 | Ferredoxin 1 | Key mediator of cuproptosis; links copper export to cell death |
| LIPT1 | Lipoyltransferase 1 | Involved in cuproptosis pathway; copper-dependent |
How Is copper ion export Regulated?
Copper ion export is tightly regulated at multiple levels. In response to elevated intracellular copper, ATP7A and ATP7B undergo rapid relocalization from the trans-Golgi network to the plasma membrane or to vesicular compartments, increasing copper efflux. This trafficking is controlled by copper binding to the N-terminal metal-binding domains of the ATPases, which masks or exposes trafficking signals. Additionally, copper availability regulates the expression of copper homeostasis genes through transcription factors such as MTF1, which induces metallothioneins and other protective proteins. In bacteria, copper export systems are regulated by copper-responsive repressors such as CopY in Enterococcus hirae, which derepresses cop operon transcription when copper is high. Post-translational modifications, including phosphorylation and ubiquitination, also modulate exporter stability and activity. In astrocytes, copper export is stimulated by extracellular copper and involves ATP7A-dependent mechanisms. Overall, regulation ensures that copper export capacity matches cellular copper load to prevent toxicity while preserving essential copper-dependent processes.
copper ion export and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP7A | Menkes disease (copper deficiency) | Knockout mice, patient-derived fibroblasts, CRISPR point mutations |
| ATP7B | Wilson disease (copper overload) | Liver-specific knockout mice, hepatocyte cell lines, knock-in of patient mutations |
| CopA | Bacterial virulence and copper resistance | Streptococcus pyogenes deletion mutants, infection models |
| GLRX1 | Inflammatory bowel disease and copper toxicity | Intestinal epithelial cell knockout, colitis models |
| FDX1 | Cuproptosis and cancer therapy | Cancer cell lines with knockout or overexpression, xenografts |
Menkes disease and copper deficiency
Menkes disease is an X-linked recessive disorder caused by mutations in ATP7A, which impairs copper export from intestinal enterocytes and other cells. This leads to systemic copper deficiency, affecting cuproenzymes such as lysyl oxidase, tyrosinase, and cytochrome c oxidase. Patients present with kinky hair, connective tissue abnormalities, and severe neurodegeneration. The defect in copper export prevents copper from reaching the bloodstream, causing copper accumulation in some tissues but deficiency in others. Research on ATP7A trafficking and function is critical for developing therapies for Menkes disease.
Wilson disease and copper overload
Wilson disease is an autosomal recessive disorder caused by mutations in ATP7B, which is required for biliary copper excretion and ceruloplasmin loading. Loss of ATP7B function leads to copper accumulation in the liver, brain, and other organs, causing hepatic cirrhosis, neurological symptoms, and psychiatric disturbances. Copper export into bile is a major route of copper elimination, and its failure results in progressive copper toxicity. Studies of ATP7B mutants and copper export mechanisms inform chelation and gene therapy strategies for Wilson disease.
Copper export in cancer and cuproptosis
Copper homeostasis is dysregulated in many cancers, and copper export capacity can influence tumor cell survival. Cuproptosis is a recently described form of copper-dependent cell death triggered by excessive intracellular copper, which targets lipoylated enzymes in the TCA cycle. Triptolide has been shown to induce cuproptosis in cervical cancer cells, suggesting that manipulating copper export pathways could be a therapeutic strategy. Cancer cells may upregulate copper export to avoid copper-induced toxicity, making exporters potential drug targets. Understanding how copper export is regulated in cancer could lead to new treatments that exploit copper dysregulation.
Bacterial copper export and virulence
Pathogenic bacteria must export copper to survive within host environments where copper is used as an antimicrobial weapon. In Streptococcus pyogenes, the CopA copper exporter is required for resistance to copper stress and for full virulence in animal models. Similarly, Enterococcus hirae uses CopA and CopB to maintain copper homeostasis. Inhibiting bacterial copper export could sensitize pathogens to host copper toxicity, representing a novel antibacterial strategy. Research on bacterial copper export also provides insights into the evolution of metal resistance.
From copper ion export-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP7A impair copper export? | CRISPR knockout of ATP7A in HeLa or fibroblast cells |
| How do disease-causing point mutations affect ATP7B function? | Knock-in of specific ATP7B mutations in HepG2 cells |
| Can we visualize copper export in real time? | Knock-in of fluorescent tags on ATP7A/ATP7B in cell lines |
| Does overexpression of CopA increase copper resistance? | Overexpression of CopA in Streptococcus pyogenes |
| What is the role of GLRX1 in copper toxicity? | Knockout of GLRX1 in intestinal epithelial cells |
| Can copper export be targeted to induce cuproptosis? | Overexpression or knockout of FDX1 in cervical cancer cells |
How to Study the copper ion export Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of copper export genes | Identify copper-responsive gene expression |
| CRISPR knockout | Loss-of-function effects on copper export | Test essentiality of ATP7A, CopA |
| Site-directed mutagenesis / knock-in | Effect of specific mutations on transport | Model Menkes/Wilson disease mutations |
| ATPase activity assay | ATP hydrolysis and copper transport rate | Measure P1B-ATPase function |
| Fluorescence microscopy | Subcellular localization and trafficking | Monitor ATP7A relocalization |
| ICP-MS | Intracellular copper content | Quantify copper export capacity |
| Copper resistance assay | Bacterial growth in high copper | Assess CopA function |
| Cuproptosis assay | Cell death induced by copper ionophores | Evaluate cancer therapy potential |
Genomic and transcriptomic approaches
RNA-seq and microarray analyses can identify changes in expression of copper export genes such as ATP7A, ATP7B, and bacterial copA under copper stress. CRISPR screens coupled with next-generation sequencing enable unbiased discovery of genes required for copper export and resistance. These methods reveal transcriptional networks and regulatory mechanisms controlling copper homeostasis.
Proteomic and biochemical assays
Western blotting, immunoprecipitation, and mass spectrometry can assess protein levels, interactions, and post-translational modifications of copper exporters. ATPase activity assays measure the catalytic function of ATP7A/ATP7B and CopA using ATP hydrolysis or copper transport into vesicles. These techniques are essential for linking genotype to biochemical function.
Imaging and trafficking studies
Fluorescence microscopy of GFP- or mCherry-tagged ATP7A/ATP7B allows visualization of copper-induced trafficking from the trans-Golgi network to the plasma membrane. Live-cell imaging with copper-sensitive dyes or genetically encoded sensors can monitor copper export dynamics in real time. These methods are powerful for studying spatial and temporal regulation of copper export.
Genetic manipulation and functional assays
CRISPR-Cas9 knockout, point mutation knock-in, and overexpression are used to test the causal role of specific genes in copper export. Copper resistance assays, such as growth in high-copper media, and cuproptosis induction assays measure the functional consequences of genetic alterations. These approaches are central to validating drug targets and understanding disease mechanisms.
How CRISPR Can Be Used to Study GO:0060003 copper ion export
Knockout
CRISPR knockout of copper export genes such as ATP7A, ATP7B, or bacterial copA allows researchers to determine their essentiality and contribution to copper homeostasis. For example, ATP7A knockout cells accumulate copper and show impaired cuproenzyme activity, mimicking Menkes disease phenotypes. In bacteria, copA deletion increases copper sensitivity and reduces virulence. Knockout models are foundational for studying loss-of-function effects.
Point Mutation
CRISPR-mediated point mutations can introduce disease-associated missense mutations into endogenous ATP7A or ATP7B loci, enabling study of mutant protein function at physiological expression levels. This approach is valuable for modeling Menkes and Wilson disease mutations and for testing pharmacological chaperones. Point mutations in bacterial copA can also reveal residues critical for copper transport and resistance.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags into copper exporter genes allows real-time visualization and biochemical purification of the transporters. Knock-in of reporter genes under the control of copper-responsive promoters can be used to monitor copper export activity in live cells. These models are essential for understanding trafficking and regulation.
Overexpression
Overexpression of copper export genes, such as ATP7A, ATP7B, or CopA, can enhance copper efflux and confer resistance to copper toxicity. In cancer research, overexpression of copper exporters may protect cells from cuproptosis, while knockdown sensitizes them. Overexpression models are useful for studying gain-of-function effects and for screening inhibitors of copper export.
How EDITGENE Supports copper ion export Research
Researchers studying copper ion export-related genes often need to determine whether a candidate gene is causally involved in copper transport, how specific mutations affect protein function, and whether modulating its expression alters cellular copper homeostasis. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for copper ion export research.
Frequently Asked Questions About copper ion export
What is copper ion export (GO:0060003)?
Copper ion export is the directed movement of copper ions out of a cell or organelle, as defined by the Gene Ontology. It is a biological process that prevents copper toxicity and maintains copper homeostasis.
What genes are involved in copper ion export?
Key genes include ATP7A and ATP7B in humans, which encode copper-transporting ATPases, and bacterial genes such as copA and copB. Other genes like ATOX1 and COMMD1 support the export process.
How does copper ion export work?
Copper is delivered to P1B-type ATPases by chaperones, and ATP hydrolysis drives conformational changes that pump copper across the membrane. This process is regulated by copper levels and transporter trafficking.
What diseases are linked to defective copper ion export?
Mutations in ATP7A cause Menkes disease, and mutations in ATP7B cause Wilson disease. Copper export defects also contribute to cancer and inflammatory conditions.
Why is copper ion export important for bacteria?
Bacterial copper export systems like CopA are required for resistance to copper stress and for virulence within hosts. They help pathogens survive the copper-rich environment of phagosomes.
How can I study copper ion export in the lab?
Common methods include CRISPR knockout of exporter genes, ATPase activity assays, fluorescence microscopy of tagged transporters, and ICP-MS to measure copper content.
What is the role of ATP7A in copper export?
ATP7A is a copper-transporting ATPase that exports copper from cells, particularly in the intestine and brain. Its dysfunction leads to Menkes disease.
What is the role of ATP7B in copper export?
ATP7B exports copper into bile and loads ceruloplasmin with copper. Its dysfunction causes Wilson disease, characterized by copper overload.
Can copper ion export be targeted for cancer therapy?
Yes, inducing copper dysregulation can trigger cuproptosis, a copper-dependent cell death. Triptolide has been shown to induce cuproptosis in cervical cancer cells.
What CRISPR models are available for copper ion export research?
EDITGENE offers knockout, point mutation knock-in, tagged knock-in, and overexpression models for copper export genes, as well as CRISPR library screening and bioinformatics services.
Conclusion
Copper ion export (GO:0060003) is a fundamental biological process that protects cells from copper toxicity while ensuring adequate copper supply for essential cuproenzymes. The P1B-type ATPases ATP7A and ATP7B are central to human copper export, and their dysfunction causes Menkes and Wilson diseases. Bacterial copper export systems are critical for virulence and represent potential antimicrobial targets. Emerging research links copper export to cancer cell survival and cuproptosis, opening new therapeutic avenues. Understanding the molecular mechanisms, regulation, and disease relevance of copper ion export requires robust experimental models. EDITGENE provides comprehensive CRISPR-based solutions to accelerate discovery in this field.
References
- 1. Scheiber I et al.. 2013. Copper: effects of deficiency and overload.. Met Ions Life Sci 13:359-87 PMID: 24470097
- 2. Xiao Y et al.. 2024. Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer.. Cell Mol Biol Lett 29(1):113 PMID: 39198750
- 3. Dao TH et al.. 2023. The role of CopA in Streptococcus pyogenes copper homeostasis and virulence.. J Inorg Biochem 240:112122 PMID: 36639322
- 4. Scheiber IF et al.. 2012. Copper export from cultured astrocytes.. Neurochem Int 60(3):292-300 PMID: 22226844
- 5. Salustros N et al.. 2022. Structural basis of ion uptake in copper-transporting P(1B)-type ATPases.. Nat Commun 13(1):5121 PMID: 36045128
- 6. Akbari MS et al.. 2022. Metal Homeostasis in Pathogenic Streptococci.. Microorganisms 10(8) PMID: 35893559
- 7. Solioz M et al.. 2003. Copper homeostasis in Enterococcus hirae.. FEMS Microbiol Rev 27(2-3):183-95 PMID: 12829267
- 8. Zhang T et al.. 2026. Glutaredoxin 1 promotes intestinal epithelial cell copper toxicity in inflammatory bowel disease.. Redox Biol 93:104164 PMID: 41985411
